Condensed Consolidated Statements of Operations (Unaudited) (USD $) In Thousands, except Per Share data, unless otherwise specified	3 Months Ended		78 Months Ended
	Mar. 31, 2012	Mar. 31, 2011	Mar. 31, 2012
Revenues	$ 0	$ 0	$ 0
Costs and expenses
Research and development	1,177	656	14,115
Selling, general and administrative	915	653	9,910
Total costs and expenses	2,092	1,309	24,025
Loss from operations	(2,092)	(1,309)	(24,025)
Other income and expense
Other income			1,147
Interest income			79
Amortization of debt issuance expense	(2)	(25)	(1,972)
Interest expense	(43)		(155)
Total other income and expense	(45)	(25)	(901)
Loss before income tax	(2,137)	(1,334)	(24,926)
Provision for income tax	0	0	0
Net loss	(2,137)	(1,334)	(24,926)
Loss attributable to common stockholders and loss per common share:
Net loss	(2,137)	(1,334)	(24,926)
Net loss attributable to common stockholders	(2,137)	(1,334)	(30,293)
Weighted average shares outstanding, basic and diluted	37,829	28,004
Net loss per basic and diluted share	$ (0.06)	$ (0.05)
Series A Preferred Conversion
Loss attributable to common stockholders and loss per common share:
Deemed dividend			(4,301)
Series A Preferred Stock
Loss attributable to common stockholders and loss per common share:
Deemed dividend			(700)
Dividends - Series A Preferred Stock			$ (366)